Bespoke Capital Acquisition Corp. (“BCAC”) is a US$360 million special purpose acquisition corp. (“SPAC”) listed on the Toronto Stock Exchange pursuing a legalized cannabis focused investment strategy.

The BCAC team brings together a depth of consumer investing experience and international consumer products brand development expertise led by Paul Walsh, former CEO of Diageo and Peter Caldini, former President of North America for Pfizer Consumer Healthcare.

BCAC’s strategy is focused on building a leading international vertically integrated cannabis company operated to the highest standards of regulatory compliance and corporate governance.